KERENDIA® (finerenone) Meets Primary Endpoint in Investigational Phase III FIND-CKD Study in Patients with Non-Diabetic Chronic Kidney Disease

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/9/2026

1. USO
2. COST
3. SPY
4. RMR
5. RXT
6. MSFT
7. MU
8. FLZH
9. IBM
10. LEVI

Go back to KERENDIA® (finerenone) Meets Primary Endpoint in Investigational Phase III FIND-CKD Study in Patients with Non-Diabetic Chronic Kidney Disease
Bay National Corporation (AMEX: BAYN) Delayed: 0.01 --0 (-0%)
Previous Close $0.01    52 Week High $0.04 
Open $61.11    52 Week Low $0.03 
Day High $0.01    P/E 0.00 
Day Low $0.01    EPS $-8.34 
Volume 358,028       

Bay National Corporation (AMEX: BAYN) Delayed: 0.01 --0 (-0%)
Previous Close $0.01    52 Week High $0.04 
Open $61.11    52 Week Low $0.03 
Day High $0.01    P/E 0.00 
Day Low $0.01    EPS $-8.34 
Volume 358,028       

Bayer Aktiengesellschaft American Depositary Shares (AMEX: BAYRY) Delayed: 14.45 --0 (-0%)
Previous Close $14.45    52 Week High $135.54 
Open $14.45    52 Week Low $94.36 
Day High $14.45    P/E N/A 
Day Low $14.45    EPS $0.00 
Volume 14,028       

Bayer AG (AMEX: BAYZF) Delayed: 56.90 --0 (-0%)
Previous Close $56.90    52 Week High $135.00 
Open $56.90    52 Week Low $94.95 
Day High $56.90    P/E N/A 
Day Low $56.90    EPS $0.00 
Volume 3,663